Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview

Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview

Cisplatin cis-(diammine)dichloridoplatinum(II) (CDDP) is the first platinum-based complex approved by the food and drug administration (FDA) of the United States (US). Cisplatin is the first line chemotherapeutic agent used alone or combined with radiations or other anti-cancer agents for a broad ra...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammad Asim Farooq, Md Aquib, Anum Farooq, Daulat Haleem Khan, Mily Bazezy Joelle Maviah, Mensura Sied Filli, Samuel Kesse, Kofi Oti Boakye-Yiadom, Rukhshona Mavlyanova, Amna Parveen, Bo Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2019-12-01
Series:Artificial Cells, Nanomedicine, and Biotechnology
Subjects:
Cisplatin
drug delivery system
polymeric nanoparticles
cancer
nanotechnology
inorganic carriers
Online Access:https://www.tandfonline.com/doi/10.1080/21691401.2019.1604535
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/21691401.2019.1604535

Similar Items